DMYD-B:STO
Diamyd Medical AB
SEK 1,00
arrow_downward
-1,38%(-0,014) 1D
5 Okt., 13:13:49 GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DMYD-B...
Open
SEK 1,00
High
SEK 1,03
Low
SEK 1,00
Mkt. cap
151,19 m
Avg. vol.
714,91 k
Volume
503,18 k
52-wk high
SEK 17,88
52-wk low
SEK 0,90
EPS
-SEK 1,98
Shares outstanding
134,00 m
No. of employees
44
Open
SEK 1,00
High
SEK 1,03
Low
SEK 1,00
Mkt. cap
151,19 m
Avg. vol.
714,91 k
Volume
503,18 k
52-wk high
SEK 17,88
52-wk low
SEK 0,90
EPS
-SEK 1,98
Shares outstanding
134,00 m
No. of employees
44
News stories
From web sources and news partners
The Daily News | Texas' Oldest Newspaper
·
15 minute gelede
NYSE logo in New York City
WFSB
·
2 uur gelede
MORNING BUSINESS REPORT: Busy week ahead on Wall Street, Social Security COLA estimate at 3.7%
Stock Titan
·
28 minute gelede
After a 1-for-30 reverse split, Megan Holdings (Nasdaq: MGN) receives Nasdaq’s compliance decision.
Yahoo Finance
·
1 uur gelede
Should You Invest in the First Trust NASDAQ Bank ETF (FTXO)?
Profile
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for type-1 diabetes. The company's investigational drug retogatein is based on a recombinant form of GAD₆₅, one of two human glutamate decarboxylase gene products.
The company is headquartered in Stockholm, and maintains a "biomanufacturing" facility in Umeå which utilizes bacuolavirus-mediated protein expression. Wikipedia
About Diamyd Medical AB